New Zealand markets closed

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0100-0.0700 (-6.48%)
At close: 04:00PM EDT
1.0600 +0.05 (+4.95%)
After hours: 04:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0800
Open1.1000
Bid0.9877 x 100
Ask1.0700 x 100
Day's range1.0100 - 1.1000
52-week range1.0000 - 4.3700
Volume128,593
Avg. volume98,501
Market cap14.543M
Beta (5Y monthly)1.65
PE ratio (TTM)N/A
EPS (TTM)-1.0500
Earnings date15 May 2024 - 20 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Microbot Medical (MBOT) Files IDE to Start Human Clinical Study

    Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.

  • GlobeNewswire

    Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

    The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this applicationBRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY® Endovascular Robotic Surgical System, announced that it has filed an Investigational Device Exemption (IDE) application with the US Food and Drug Administration (FDA). The IDE application follows the completion of multiple preclinical activities per

  • GlobeNewswire

    Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

    All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash positionBRAINTREE, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has signed a Settlement Agreement and Release with Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient II, LP, Hudson Bay Master Fund Ltd. that